Correlation Between Merck and ATyr Pharma,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and ATyr Pharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and ATyr Pharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and aTyr Pharma,, you can compare the effects of market volatilities on Merck and ATyr Pharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of ATyr Pharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and ATyr Pharma,.

Diversification Opportunities for Merck and ATyr Pharma,

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Merck and ATyr is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and aTyr Pharma, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on aTyr Pharma, and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with ATyr Pharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of aTyr Pharma, has no effect on the direction of Merck i.e., Merck and ATyr Pharma, go up and down completely randomly.

Pair Corralation between Merck and ATyr Pharma,

Considering the 90-day investment horizon Merck Company is expected to under-perform the ATyr Pharma,. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 3.2 times less risky than ATyr Pharma,. The stock trades about -0.01 of its potential returns per unit of risk. The aTyr Pharma, is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  332.00  in aTyr Pharma, on August 30, 2024 and sell it today you would earn a total of  12.00  from holding aTyr Pharma, or generate 3.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Merck Company  vs.  aTyr Pharma,

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
aTyr Pharma, 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in aTyr Pharma, are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, ATyr Pharma, reported solid returns over the last few months and may actually be approaching a breakup point.

Merck and ATyr Pharma, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and ATyr Pharma,

The main advantage of trading using opposite Merck and ATyr Pharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, ATyr Pharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma, will offset losses from the drop in ATyr Pharma,'s long position.
The idea behind Merck Company and aTyr Pharma, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like